CareDx Inc (CDNA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 64/100

gurufocus.com · 2026-10-13

On October 13, 2026, CareDx Inc (CDNA) shares rose by 3.7%, bringing the current price to $65.43. Over the past year, the stock has experienced significant vola

TickrTrends take: CareDx Inc operates in the Healthcare sector where valuation metrics warrant careful attention from investors focused on price-to-value relationships. TickrTrends currently rates CDNA as overvalued, a designation that aligns with fundamental assessment concerns despite recent positive price movement. Investors monitoring this stock should focus on whether operational improvements or market conditions might eventually justify the current valuation levels.

Read the full story at gurufocus.com →